StockDrifts LogoStockDrifts

Jeil Bio 052670

Company
제일바이오Jeil Bio
Insiders
2
Buys
6
Total Value
₩123M ($86K)
Avg Return
-12.66%
Last Filing
2026-02-24

Jeil Bio (052670) has 6 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩123M ($86K) in reported transaction value. The earliest filing StockDrifts holds for Jeil Bio is dated 2024-12-02; the most recent is 2026-02-24. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -12.66%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-02-24BUYMarket Buy
심의정
Sim Ui-jeong
Sales Manager735---
2026-02-24BUYMarket Buy
심광경
Shim Kwang-kyung
Honorary Chairman590---
2026-02-23BUYMarket Buy
심의정
Sim Ui-jeong
Sales Manager245---
2026-02-23BUYMarket Buy
심광경
Shim Kwang-kyung
Honorary Chairman277---
2026-02-20BUYMarket Buy
심광경
Shim Kwang-kyung
Honorary Chairman278₩320,000+0.0%₩89M ($62K)
2026-02-19BUYMarket Buy
심광경
Shim Kwang-kyung
Honorary Chairman80₩428,500-25.3%₩34M ($24K)
2026-02-09SELL주식병합
심광경
Shim Kwang-kyung
Honorary Chairman-2.1M₩625,000+48.8%₩1.3T ($927.9M)
2026-02-09SELL주식병합
심의정
Sim Ui-jeong
Sales Manager-4.2M₩625,000+48.8%₩2.6T ($1.8B)
2026-02-09SELL주식병합
강동일
Kang Dong-il
CEO-249.9K₩625,000+48.8%₩156.2B ($108.5M)
2025-06-23BUY자사주상여금
강동일
Kang Dong-il
CEO250.1K₩2,080+15284.6%₩520M ($361K)
2025-06-23BUY자사주상여금
심의정
Sim Ui-jeong
Sales Manager67.5K₩2,080+15284.6%₩140M ($97K)
2025-06-23BUY자사주상여금
심광경
Shim Kwang-kyung
Honorary Chairman67.5K₩2,080+15284.6%₩140M ($97K)
2024-12-02BUY합병
심의정
Sim Ui-jeong
Sales Manager67.9K₩2,080+15284.6%₩141M ($98K)

Frequently asked questions

Who has been buying Jeil Bio stock?
2 distinct insiders have filed 6 disclosed insider purchases in Jeil Bio (052670), most recently on 2026-02-24. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Jeil Bio have?
Jeil Bio has 6 buy-side and 0 sell-side disclosures on record, covering ₩123M ($86K) in total reported value, spanning 2024-12-02 to 2026-02-24.
Where does StockDrifts get Jeil Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Jeil Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.